RNF114 and cataract: To increase drug concentration within the lens, we engineered an RNF114 peptide fused with TAT to enhance its delivery into the lens; synthetic TAT-RNF114 has demonstrated efficacy in reversing the aggregation of mutant CRYAA and mitigating the irreversible lens opacification associated with cold-induced and oxidative cataracts in rats.